WEBVTT - Lab 042: Understanding HIV Part I

0:00:00.720 --> 0:00:04.040
<v Speaker 1>December first was World Aid's Day, and December the entire

0:00:04.080 --> 0:00:06.880
<v Speaker 1>month is HIV Awareness Month.

0:00:06.760 --> 0:00:10.040
<v Speaker 2>And this December is particularly important because it's the fortieth

0:00:10.039 --> 0:00:13.760
<v Speaker 2>anniversary of the first five cases of HIV.

0:00:14.120 --> 0:00:17.640
<v Speaker 1>Wow, forty years feels like not a long time, but

0:00:17.800 --> 0:00:20.079
<v Speaker 1>so much has happened in those forty years.

0:00:20.079 --> 0:00:23.279
<v Speaker 2>It's definitely not a long scientific time, you know, And

0:00:23.360 --> 0:00:26.360
<v Speaker 2>you're right, so much has happened. Even thinking about what

0:00:26.440 --> 0:00:29.880
<v Speaker 2>it meant to have HIV in the eighties and what

0:00:29.920 --> 0:00:32.280
<v Speaker 2>it meant for your life compared to what it means

0:00:32.280 --> 0:00:35.879
<v Speaker 2>now thanks to advances in medicine and vaxine development, all

0:00:35.960 --> 0:00:38.040
<v Speaker 2>kinds of things that are coming along for the treatment

0:00:38.040 --> 0:00:39.360
<v Speaker 2>of HIV and AIDS.

0:00:39.200 --> 0:00:43.240
<v Speaker 1>Right, and our understanding I think of the virus has changed, yes,

0:00:43.440 --> 0:00:46.280
<v Speaker 1>and the way that we interact with people who have

0:00:46.520 --> 0:00:48.440
<v Speaker 1>HIV has changed, thankfully.

0:00:48.640 --> 0:00:51.400
<v Speaker 2>You're right. I think there's so much to unpack even

0:00:51.400 --> 0:00:55.960
<v Speaker 2>though it's a short scientific time. There have been incredible developments, absolutely,

0:00:56.000 --> 0:01:08.319
<v Speaker 2>and I can't wait for us to learn all about it.

0:01:23.240 --> 0:01:27.080
<v Speaker 1>Welcome to Dope Labs, a weekly podcast that mixes hardcore science,

0:01:27.240 --> 0:01:29.319
<v Speaker 1>pop culture, and a healthy dose of friendship.

0:01:29.520 --> 0:01:32.920
<v Speaker 2>This week, we're talking all about HIV Now, HIV has

0:01:32.920 --> 0:01:35.080
<v Speaker 2>been around for a while, and there's been all kinds

0:01:35.080 --> 0:01:37.039
<v Speaker 2>of rumors like, oh, they have a cure and the

0:01:37.080 --> 0:01:39.399
<v Speaker 2>government just doesn't want us to have it. But scientists

0:01:39.440 --> 0:01:41.720
<v Speaker 2>have been working on an HIV vaccine for a pretty

0:01:41.760 --> 0:01:44.640
<v Speaker 2>long time. Yeah, there's a lot swirling around, But what's

0:01:44.760 --> 0:01:47.319
<v Speaker 2>most important is what the science is telling us, and

0:01:47.400 --> 0:01:49.200
<v Speaker 2>that's what we're going to get into today. I just

0:01:49.240 --> 0:01:52.160
<v Speaker 2>saw this story in the Washington Post about an Argentinian

0:01:52.200 --> 0:01:56.080
<v Speaker 2>woman who just became the second person on record whose

0:01:56.120 --> 0:02:00.240
<v Speaker 2>body might have completely eliminated the HIV virus on its own.

0:02:00.440 --> 0:02:02.800
<v Speaker 2>And when something like this happens, it's a huge deal

0:02:02.880 --> 0:02:05.880
<v Speaker 2>for scientists who can study what happened in the patient's

0:02:05.920 --> 0:02:09.040
<v Speaker 2>body and potentially use those findings to develop a cure.

0:02:09.440 --> 0:02:13.639
<v Speaker 2>Let's get into the recitation.

0:02:21.520 --> 0:02:22.320
<v Speaker 1>So what do we know.

0:02:22.639 --> 0:02:25.400
<v Speaker 2>Well, we know HIV stands for the human immuno deficiency

0:02:25.520 --> 0:02:28.200
<v Speaker 2>virus and it's been around for a long time. It's

0:02:28.240 --> 0:02:30.560
<v Speaker 2>been about forty years since the first case of HIV

0:02:30.720 --> 0:02:31.400
<v Speaker 2>was diagnosed.

0:02:31.639 --> 0:02:34.919
<v Speaker 1>We also know that HIV is the virus that causes AIDS,

0:02:34.960 --> 0:02:37.640
<v Speaker 1>so that's similar to how SARS CoV two is the

0:02:37.720 --> 0:02:40.800
<v Speaker 1>virus that can lead to COVID nineteen and HIV affects

0:02:40.800 --> 0:02:41.440
<v Speaker 1>a lot of people.

0:02:41.520 --> 0:02:44.680
<v Speaker 2>So about thirty seven million people worldwide have HIV, and

0:02:45.040 --> 0:02:47.279
<v Speaker 2>about one point two million of those are Americans.

0:02:47.480 --> 0:02:50.040
<v Speaker 1>And we know that HIV is a virus that attacks

0:02:50.040 --> 0:02:52.600
<v Speaker 1>the body's immune system and if it goes untreated, it

0:02:52.600 --> 0:02:55.919
<v Speaker 1>can lead to AIDS. So currently there's no cure for HIV,

0:02:56.040 --> 0:02:58.520
<v Speaker 1>but there are ways to control it through treatment that

0:02:58.600 --> 0:03:01.960
<v Speaker 1>allow those living with HIV to have long, healthy lives.

0:03:02.240 --> 0:03:04.000
<v Speaker 1>So what do we want to know? I think I

0:03:04.040 --> 0:03:08.200
<v Speaker 1>want to know how is the vaccine development for HIV

0:03:08.560 --> 0:03:11.280
<v Speaker 1>different from other types of vaccine development. We've talked about

0:03:11.320 --> 0:03:15.119
<v Speaker 1>vaccine development in previous labs, and so I'm curious if

0:03:15.120 --> 0:03:18.160
<v Speaker 1>it's the same, it's different, and if it's different, how

0:03:18.240 --> 0:03:18.760
<v Speaker 1>is it different?

0:03:18.840 --> 0:03:21.480
<v Speaker 2>And I think before we can even get to vaccine development,

0:03:21.760 --> 0:03:25.519
<v Speaker 2>I need to know some basic biology about HIV. What's

0:03:25.520 --> 0:03:26.959
<v Speaker 2>it looking like, how's it working?

0:03:27.160 --> 0:03:27.320
<v Speaker 3>You know?

0:03:27.320 --> 0:03:28.720
<v Speaker 2>I think we have to kind of understand those things

0:03:28.760 --> 0:03:30.120
<v Speaker 2>before we know how we're going to stop it in

0:03:30.160 --> 0:03:32.200
<v Speaker 2>its tracks. I also want to know the timeline to

0:03:32.240 --> 0:03:34.519
<v Speaker 2>getting here. We didn't just start trying to make a

0:03:34.600 --> 0:03:38.560
<v Speaker 2>vaccine first. There were medicines made available that now feel

0:03:38.600 --> 0:03:41.080
<v Speaker 2>like super medicines compared to what may have seemed possible

0:03:41.120 --> 0:03:43.400
<v Speaker 2>in the eighties. So there are things that can make

0:03:43.600 --> 0:03:47.520
<v Speaker 2>HIV undetectable and thus non transmissible. And why is this

0:03:47.600 --> 0:03:51.560
<v Speaker 2>virus so different from other viruses that it's taken so

0:03:51.920 --> 0:03:54.520
<v Speaker 2>long to develop a vaccine? COVID got us one in

0:03:54.560 --> 0:03:58.200
<v Speaker 2>the vaccine in two years every time, yet hyper speed.

0:03:58.320 --> 0:04:01.480
<v Speaker 2>But this is a very good question. Let's jump into

0:04:01.480 --> 0:04:10.360
<v Speaker 2>the dissection. Our guest for the next two laps is

0:04:10.360 --> 0:04:11.680
<v Speaker 2>doctor Christine Daniels.

0:04:11.720 --> 0:04:14.000
<v Speaker 4>My name is Christine Daniels, and I recently finished my

0:04:14.040 --> 0:04:17.480
<v Speaker 4>post doc at Duke University's Human Vaccine Institute. Christine's work

0:04:17.520 --> 0:04:22.039
<v Speaker 4>focuses on developing and testing novel or new vaccine candidates.

0:04:22.320 --> 0:04:25.680
<v Speaker 1>Christine is another one of me and Zakia's actual friends

0:04:25.680 --> 0:04:27.960
<v Speaker 1>in real life. We always tell you we know some

0:04:28.160 --> 0:04:30.479
<v Speaker 1>very smart people. We all went to Douke at the

0:04:30.560 --> 0:04:34.120
<v Speaker 1>same time, and so you might hear us call her Christine,

0:04:34.360 --> 0:04:41.159
<v Speaker 1>but it is definitely doctor Daniels. Okay, so first things first,

0:04:41.240 --> 0:04:45.280
<v Speaker 1>let's talk about the HIV virus and to understand what

0:04:45.320 --> 0:04:47.360
<v Speaker 1>it is and how it works. We ask doctor Daniels

0:04:47.400 --> 0:04:50.080
<v Speaker 1>to explain it to us in the context of sarskov two,

0:04:50.279 --> 0:04:51.960
<v Speaker 1>the virus that causes COVID nineteen.

0:04:52.200 --> 0:04:55.960
<v Speaker 4>So broadly speaking, HIV and sarskobe two are very similar.

0:04:56.040 --> 0:04:58.760
<v Speaker 2>Let's start with their structure. HIV and sars kov two

0:04:58.880 --> 0:05:00.000
<v Speaker 2>have a pretty similar structure.

0:05:00.160 --> 0:05:01.640
<v Speaker 3>They're both envelope viruses.

0:05:01.839 --> 0:05:04.880
<v Speaker 1>This means that the virus is surrounded by an outer shell.

0:05:05.120 --> 0:05:06.360
<v Speaker 3>They're both expressed.

0:05:06.400 --> 0:05:11.440
<v Speaker 4>Their glycoproteins, or their spike proteins per se on their surface.

0:05:11.160 --> 0:05:13.560
<v Speaker 2>So that envelope or outer shell of the virus is

0:05:13.560 --> 0:05:17.000
<v Speaker 2>covered in these little spikes or proteins, and those proteins

0:05:17.040 --> 0:05:19.800
<v Speaker 2>have little sugars that's the glyco attached to them, and

0:05:19.880 --> 0:05:23.560
<v Speaker 2>those proteins allow the virus to bind or dock onto

0:05:23.600 --> 0:05:25.760
<v Speaker 2>host cells and that leads to infection.

0:05:26.000 --> 0:05:29.760
<v Speaker 1>And HIV and sarscov two are also similar in terms

0:05:29.839 --> 0:05:31.120
<v Speaker 1>of their genetic material.

0:05:31.279 --> 0:05:32.680
<v Speaker 3>They're both RNA viruses.

0:05:32.880 --> 0:05:36.240
<v Speaker 2>This means that they have single stranded RNA or ribonucleic

0:05:36.279 --> 0:05:39.520
<v Speaker 2>acid as their genetic material instead of double stranded DNA

0:05:39.640 --> 0:05:40.479
<v Speaker 2>like human cells have.

0:05:40.880 --> 0:05:45.839
<v Speaker 1>So in each HIV particle, you've got RNA inside surrounded

0:05:45.880 --> 0:05:50.039
<v Speaker 1>by the envelope with a bunch of little spikes all over.

0:05:50.320 --> 0:05:54.240
<v Speaker 1>Called glycoproteins, and so when HIV enters the bloodstream and

0:05:54.320 --> 0:05:56.800
<v Speaker 1>makes contact with the sell those little spikes are attaching

0:05:56.839 --> 0:05:59.159
<v Speaker 1>to the surface and they begin to fuse with the

0:05:59.160 --> 0:06:02.200
<v Speaker 1>host cell. This allows the center of the HIV particle,

0:06:02.200 --> 0:06:04.640
<v Speaker 1>that RNA, to go right into the whole sale and

0:06:04.720 --> 0:06:08.560
<v Speaker 1>to get converted back into DNA. So now you've got

0:06:08.640 --> 0:06:12.160
<v Speaker 1>viral DNA in your wholesale. So from there, the wholesale

0:06:12.240 --> 0:06:15.360
<v Speaker 1>is hijacked by HIV and begins to make more HIV

0:06:15.440 --> 0:06:19.040
<v Speaker 1>particles inside the body. But our body has an amazing

0:06:19.360 --> 0:06:22.359
<v Speaker 1>natural defense when it comes to fighting off viruses, the

0:06:22.400 --> 0:06:25.720
<v Speaker 1>immune system, and when our immune system senses that there

0:06:25.800 --> 0:06:29.120
<v Speaker 1>is an intruder, it can unleash a swarm of targeted

0:06:29.320 --> 0:06:33.360
<v Speaker 1>and general antibodies that will attack the virus, neutralizing it.

0:06:33.520 --> 0:06:35.920
<v Speaker 2>So remember those spikes we talked about covering the outside

0:06:35.960 --> 0:06:40.240
<v Speaker 2>of the virus. Those glycoproteins are what's specifically targeted by antibodies.

0:06:40.440 --> 0:06:45.440
<v Speaker 2>So stars CoV two and HIV viruses are structurally so similar.

0:06:45.600 --> 0:06:48.240
<v Speaker 2>In fact, the decades that have gone into developing the

0:06:48.400 --> 0:06:52.000
<v Speaker 2>HIV vaccine made it possible to develop the COVID vaccine

0:06:52.040 --> 0:06:53.000
<v Speaker 2>so quickly.

0:06:52.960 --> 0:06:56.440
<v Speaker 4>Because they're so structurally similar, we're able to leverage the

0:06:56.480 --> 0:06:59.320
<v Speaker 4>structure based a vaccine platform to design a vaccine for

0:06:59.360 --> 0:07:00.000
<v Speaker 4>COVID nineteen.

0:07:00.120 --> 0:07:03.320
<v Speaker 2>So understanding what the virus looks like structurally, what happens

0:07:03.320 --> 0:07:06.600
<v Speaker 2>when it gets into your body? How are vaccines disrupting

0:07:06.640 --> 0:07:09.159
<v Speaker 2>this process? How do they work? Doctor Daniels gave us

0:07:09.160 --> 0:07:12.640
<v Speaker 2>a great analogy. She thinks of a vaccine like a mugshot.

0:07:12.720 --> 0:07:14.840
<v Speaker 2>The vaccine is going to tell your body, Hey, this

0:07:14.880 --> 0:07:16.960
<v Speaker 2>is who you're looking for. This particle looks like this,

0:07:17.120 --> 0:07:19.600
<v Speaker 2>It has this certain protein on it. When you see it,

0:07:19.720 --> 0:07:30.800
<v Speaker 2>you know what to do. All systems go.

0:07:34.120 --> 0:07:37.240
<v Speaker 1>Now that we know generally how the HIV particle is

0:07:37.320 --> 0:07:41.480
<v Speaker 1>structured and how vaccines work in general, how would an

0:07:41.520 --> 0:07:43.840
<v Speaker 1>effective HIV vaccine work.

0:07:44.080 --> 0:07:47.360
<v Speaker 4>My lab specialized in protein design and expression, so we

0:07:47.480 --> 0:07:49.960
<v Speaker 4>use what we know about how the natural virus is

0:07:50.000 --> 0:07:52.520
<v Speaker 4>structured in its modes of infections in order to design

0:07:52.560 --> 0:07:56.160
<v Speaker 4>synthetic versions of it that mimic the virus but aren't infectious.

0:07:56.320 --> 0:07:58.480
<v Speaker 4>And using what we know, we're able to modify these

0:07:58.480 --> 0:08:01.600
<v Speaker 4>synthetic versions of the virus to help increase the body's

0:08:01.680 --> 0:08:05.400
<v Speaker 4>chances of recognizing them. Basically, instead of trying to redesign

0:08:05.400 --> 0:08:07.760
<v Speaker 4>a fake version of the entire virus. You just take

0:08:07.800 --> 0:08:09.880
<v Speaker 4>the piece of the virus that your body sees and

0:08:09.920 --> 0:08:12.120
<v Speaker 4>develops an immune response against, and that piece of the

0:08:12.280 --> 0:08:15.040
<v Speaker 4>HIV virus that your body sees, that's those spike proteins

0:08:15.040 --> 0:08:17.080
<v Speaker 4>we talked about that are spread out all over the

0:08:17.160 --> 0:08:19.880
<v Speaker 4>envelope of the virus, the glycoproteins. So you have this

0:08:19.920 --> 0:08:22.560
<v Speaker 4>big virus and you have these proteins spiking all over

0:08:22.560 --> 0:08:24.920
<v Speaker 4>the surface. We just take one of those spike proteins

0:08:24.920 --> 0:08:26.280
<v Speaker 4>and we just want to show that to the body

0:08:26.360 --> 0:08:30.040
<v Speaker 4>so the body focuses on the right region. The problem is, though,

0:08:30.120 --> 0:08:32.880
<v Speaker 4>that sometimes just one little piece isn't enough for the

0:08:32.880 --> 0:08:35.959
<v Speaker 4>body to generate a strong immune response. And so what

0:08:36.000 --> 0:08:38.040
<v Speaker 4>you can do is you can attach that piece, so

0:08:38.120 --> 0:08:41.520
<v Speaker 4>that spike that envelope protein onto a nanoparticle and you

0:08:41.520 --> 0:08:43.920
<v Speaker 4>can display multiple copies, so it's kind of like a

0:08:43.920 --> 0:08:46.760
<v Speaker 4>mini virus. And also the NATO particle itself is composed

0:08:46.800 --> 0:08:49.679
<v Speaker 4>of materials that will also activate your immune response. So

0:08:49.720 --> 0:08:52.000
<v Speaker 4>you get a robust immune response because you're showing multiple

0:08:52.000 --> 0:08:54.760
<v Speaker 4>copies of the right target. And then you have something

0:08:54.840 --> 0:08:58.439
<v Speaker 4>else that's stimulating supporting cells to help enhance that immune response.

0:08:58.679 --> 0:09:01.000
<v Speaker 1>All of this is blowing my mind. So doctor Daniels

0:09:01.000 --> 0:09:03.439
<v Speaker 1>works on creating a copy of the envelope of an

0:09:03.559 --> 0:09:07.560
<v Speaker 1>HIV particle covered in those glycoprotein spikes that your body

0:09:07.559 --> 0:09:10.480
<v Speaker 1>will recognize and develop a defense against. And by the way,

0:09:10.600 --> 0:09:14.600
<v Speaker 1>sorry's CoV two vaccines. You know, Maderna, Pfizer, and Johnson

0:09:14.600 --> 0:09:18.360
<v Speaker 1>and Johnson. They may have different strategies, but they all

0:09:18.440 --> 0:09:21.320
<v Speaker 1>are working towards the same goal to help your body

0:09:21.320 --> 0:09:25.440
<v Speaker 1>create a strong immune response against the coronavirus spike protein

0:09:25.600 --> 0:09:27.600
<v Speaker 1>that surrounds the virus.

0:09:27.360 --> 0:09:30.840
<v Speaker 2>And antibodies are one part of that immune response. Antibodies

0:09:30.880 --> 0:09:34.120
<v Speaker 2>are tiny proteins that help your body recognize and clear

0:09:34.320 --> 0:09:37.920
<v Speaker 2>foreign toxins, bacteria, and viral particles.

0:09:38.080 --> 0:09:39.800
<v Speaker 1>So they're like the bouncers outside the club.

0:09:40.160 --> 0:09:45.040
<v Speaker 2>Yes, that's perfect, And Christine mentions neutralizing antibodies And if

0:09:45.080 --> 0:09:49.000
<v Speaker 2>you play on that bouncer metaphor, neutralizing antibodies are binding

0:09:49.040 --> 0:09:51.760
<v Speaker 2>to the outside of a viral particle, so that those

0:09:51.800 --> 0:09:54.199
<v Speaker 2>spike proteins can't bind to any whost sales. So it's

0:09:54.280 --> 0:09:56.880
<v Speaker 2>like if the bouncers make a circle around you, right,

0:09:57.480 --> 0:10:00.600
<v Speaker 2>don't have contact, You're not what I see like when

0:10:00.600 --> 0:10:02.319
<v Speaker 2>they pick you up, when they hold the arms and

0:10:02.360 --> 0:10:04.520
<v Speaker 2>the legs and carry you out the club. That's what

0:10:04.559 --> 0:10:06.000
<v Speaker 2>neutralizing antibodies are doing.

0:10:06.040 --> 0:10:08.600
<v Speaker 1>I've seen that happen to some people. It's pretty embarrassing.

0:10:08.720 --> 0:10:12.360
<v Speaker 1>They say, your evening is over, it's time to retire

0:10:12.440 --> 0:10:13.160
<v Speaker 1>to the boudoir.

0:10:15.520 --> 0:10:18.040
<v Speaker 2>This is really amazing work. Tt It feels like something

0:10:18.200 --> 0:10:21.040
<v Speaker 2>we would do if we had a lab together. Yeah,

0:10:21.160 --> 0:10:23.199
<v Speaker 2>biology with nanoparticles.

0:10:23.320 --> 0:10:24.760
<v Speaker 1>Oh yeah, we'd be all over it.

0:10:24.800 --> 0:10:26.760
<v Speaker 2>Man, this must be really challenging work though.

0:10:27.360 --> 0:10:29.040
<v Speaker 1>Yes, I don't want to pretend like I know how

0:10:29.040 --> 0:10:32.840
<v Speaker 1>to do everything with nanoparticles same, but it sounds so cool.

0:10:33.120 --> 0:10:33.880
<v Speaker 1>I would love this.

0:10:34.120 --> 0:10:35.760
<v Speaker 2>All right, we're going to take a break, but when

0:10:35.800 --> 0:10:37.440
<v Speaker 2>we get back, we're going to talk to doctor Daniels

0:10:37.440 --> 0:10:39.920
<v Speaker 2>about the progress we've made so far towards an effective

0:10:40.040 --> 0:10:42.400
<v Speaker 2>HIV vaccine and how far we have to go.

0:11:01.480 --> 0:11:03.600
<v Speaker 1>We're back and right before we want to break, we

0:11:03.679 --> 0:11:08.559
<v Speaker 1>talked about non neutralizing antibodies, neutralizing antibodies and everything in between.

0:11:08.800 --> 0:11:11.200
<v Speaker 1>But if you want to know more about that, make

0:11:11.240 --> 0:11:13.719
<v Speaker 1>sure that you tune into our episodes in the New Year,

0:11:13.720 --> 0:11:17.200
<v Speaker 1>where we're talking all about the immune system. And before

0:11:17.240 --> 0:11:20.120
<v Speaker 1>we get back to talking about the HIV vaccine Zakia.

0:11:20.200 --> 0:11:21.520
<v Speaker 1>What's on tap next week.

0:11:21.800 --> 0:11:24.720
<v Speaker 2>Next week, we're continuing our conversation with doctor Daniels around

0:11:24.720 --> 0:11:27.880
<v Speaker 2>the development of an effective HIV vaccine, But we're gonna

0:11:27.880 --> 0:11:30.240
<v Speaker 2>shift the lens just a little bit from the science

0:11:30.360 --> 0:11:33.040
<v Speaker 2>to the people, because we know science doesn't happen in

0:11:33.080 --> 0:11:35.720
<v Speaker 2>a vacuum. So we'll be talking through the social context

0:11:35.720 --> 0:11:38.920
<v Speaker 2>around HIV over the past forty years and the people

0:11:38.920 --> 0:11:40.079
<v Speaker 2>who are affected most.

0:11:40.480 --> 0:11:41.920
<v Speaker 1>All right, let's get back to the show.

0:11:43.920 --> 0:11:46.719
<v Speaker 2>So here's what I want to know. We understand the similarities,

0:11:47.040 --> 0:11:49.880
<v Speaker 2>and we understand that work on the HIV vaccine could

0:11:49.920 --> 0:11:53.520
<v Speaker 2>have provided some scaffolding for process and distribution and other

0:11:53.559 --> 0:11:56.360
<v Speaker 2>developments with the COVID nineteen vaccine. But the COVID nineteen

0:11:56.440 --> 0:11:58.760
<v Speaker 2>vaccine got up and running pretty quickly, and we know,

0:11:59.120 --> 0:12:00.760
<v Speaker 2>you know a lot of people we're working on it.

0:12:00.800 --> 0:12:01.240
<v Speaker 2>A lot of.

0:12:01.200 --> 0:12:02.440
<v Speaker 1>Resources were poured into it.

0:12:02.920 --> 0:12:05.640
<v Speaker 2>What's been taking the HIV vaccine, which has been a

0:12:05.640 --> 0:12:08.320
<v Speaker 2>development for many decades, what's been taking it so long?

0:12:08.440 --> 0:12:11.319
<v Speaker 2>So COVID was developed really quickly because it's an easier

0:12:11.360 --> 0:12:13.439
<v Speaker 2>pathogen to design a vaccine against.

0:12:13.480 --> 0:12:17.640
<v Speaker 1>So even though HIV and SARS CoV two are structurally

0:12:17.760 --> 0:12:21.559
<v Speaker 1>similar and are both RNA viruses that use RNA as

0:12:21.600 --> 0:12:25.280
<v Speaker 1>their primary genetic material. A major difference is that SARS

0:12:25.280 --> 0:12:28.440
<v Speaker 1>CoV two doesn't mutate as frequently as HIV.

0:12:29.040 --> 0:12:33.280
<v Speaker 4>HIV mutates incredibly quickly. It can incur about ten mutations

0:12:33.320 --> 0:12:36.400
<v Speaker 4>per replication cycle, and the replication cycle is less than

0:12:36.440 --> 0:12:39.320
<v Speaker 4>twenty four hours. Scientists have estimate that one mutation of

0:12:39.360 --> 0:12:42.680
<v Speaker 4>SARS CoV two is established every eleven days or so.

0:12:42.679 --> 0:12:46.280
<v Speaker 4>So now we're looking at HIV having a mutation rate

0:12:46.320 --> 0:12:49.680
<v Speaker 4>this four times that of sars CoV two. So developing

0:12:49.679 --> 0:12:52.760
<v Speaker 4>a vaccine is able to accommodate all of that variation,

0:12:52.840 --> 0:12:55.600
<v Speaker 4>it's just really hard to do. So the way that

0:12:55.640 --> 0:12:58.440
<v Speaker 4>we try to do that is by designing vaccines that

0:12:58.480 --> 0:13:01.679
<v Speaker 4>are based on the conserved or of the HIV virus,

0:13:01.840 --> 0:13:04.240
<v Speaker 4>and so even if the virus mutates, those are regions

0:13:04.280 --> 0:13:07.600
<v Speaker 4>that don't mutate as frequently, and so if you get

0:13:07.640 --> 0:13:10.000
<v Speaker 4>a response against those sites, then you can likely be

0:13:10.040 --> 0:13:13.600
<v Speaker 4>protected against a wide range of viruses. So that's the approach,

0:13:13.600 --> 0:13:15.600
<v Speaker 4>and that theoretically you know that should work.

0:13:15.760 --> 0:13:19.200
<v Speaker 1>The other challenge for developing an HIV vaccine is the

0:13:19.320 --> 0:13:23.160
<v Speaker 1>length of time of infection. The infection window for sarskov

0:13:23.280 --> 0:13:27.000
<v Speaker 1>two is much shorter than HIV, and like we said before,

0:13:27.240 --> 0:13:31.240
<v Speaker 1>once someone is infected, that person has HIV for life

0:13:31.320 --> 0:13:32.880
<v Speaker 1>with very few exceptions.

0:13:32.960 --> 0:13:36.520
<v Speaker 4>So an HIV infected individual can live with HIV and

0:13:36.559 --> 0:13:38.880
<v Speaker 4>not experience any symptoms for a long time even though

0:13:38.880 --> 0:13:41.760
<v Speaker 4>they're infected with virus and it's infecting a body, and

0:13:41.800 --> 0:13:43.480
<v Speaker 4>not display symptom until they're very sick.

0:13:43.559 --> 0:13:46.480
<v Speaker 2>That also means there's a much longer window for HIV

0:13:46.640 --> 0:13:48.480
<v Speaker 2>to replicate inside your body, so.

0:13:48.440 --> 0:13:51.320
<v Speaker 4>It can mutate, but it's less probable just based on

0:13:51.360 --> 0:13:53.280
<v Speaker 4>that time window and the amount of times that would

0:13:53.320 --> 0:13:55.720
<v Speaker 4>have to replicate in a person within that time window.

0:13:56.000 --> 0:13:59.959
<v Speaker 1>And lastly, HIV is particularly elusive because it's able to

0:14:00.280 --> 0:14:03.600
<v Speaker 1>essentially hide itself from the immune system until it's too late.

0:14:04.080 --> 0:14:08.080
<v Speaker 1>HIV is covered with these sugars called glycans. The glycans

0:14:08.080 --> 0:14:11.240
<v Speaker 1>can attach to the envelope, that hard candy shell of

0:14:11.320 --> 0:14:14.840
<v Speaker 1>the virus and effectively hide the spike proteins from any

0:14:14.920 --> 0:14:17.679
<v Speaker 1>suspecting antibodies. So that's the challenge.

0:14:17.760 --> 0:14:19.960
<v Speaker 4>How do you generate a response that is able to

0:14:20.080 --> 0:14:22.880
<v Speaker 4>learn to bind or obade those black cans to target

0:14:22.920 --> 0:14:23.280
<v Speaker 4>the site.

0:14:23.440 --> 0:14:25.600
<v Speaker 2>That's really tricky because cells in our body naturally have

0:14:25.680 --> 0:14:28.840
<v Speaker 2>glycans all over them, So your immune system isn't going

0:14:28.960 --> 0:14:31.160
<v Speaker 2>to kick in the gear when it sees glycans because

0:14:31.200 --> 0:14:33.600
<v Speaker 2>that would mean you're essentially attacking yourself.

0:14:33.880 --> 0:14:37.240
<v Speaker 4>So in order to generate an effective HIV vaccine, we

0:14:37.280 --> 0:14:39.800
<v Speaker 4>need to figure out a way to generate antibodies that

0:14:39.880 --> 0:14:42.520
<v Speaker 4>are able to bind to the glycans and to the

0:14:42.560 --> 0:14:45.560
<v Speaker 4>protein at the same times. That way they won't be autoreactive.

0:14:45.680 --> 0:14:46.680
<v Speaker 4>And that's just hard to do.

0:14:46.840 --> 0:14:50.360
<v Speaker 2>I have a new appreciation for the challenges associated with

0:14:50.440 --> 0:14:52.120
<v Speaker 2>vaccine design against HIV.

0:14:52.400 --> 0:14:55.360
<v Speaker 1>Right, imagine trying to do a puzzle and every time

0:14:55.520 --> 0:14:57.520
<v Speaker 1>you go to put a piece down, all the pieces

0:14:57.680 --> 0:14:59.000
<v Speaker 1>change their shape.

0:14:58.800 --> 0:15:00.720
<v Speaker 2>Or they're saying you basic, we got to put down

0:15:00.760 --> 0:15:02.640
<v Speaker 2>two pieces at a time glancing in protein.

0:15:02.840 --> 0:15:06.240
<v Speaker 1>Yeah, it's no wonder this vaccine is so hard to develop.

0:15:06.360 --> 0:15:10.440
<v Speaker 2>But you know, vaccines aren't the only line of defense. PREP,

0:15:10.640 --> 0:15:14.000
<v Speaker 2>which is pre exposure prophylaxis, is medicine that people can

0:15:14.040 --> 0:15:17.520
<v Speaker 2>take to prevent getting HIV. So when you take PREP

0:15:17.560 --> 0:15:21.000
<v Speaker 2>as prescribed, it will reduce your risk of contracting HIV

0:15:21.120 --> 0:15:24.800
<v Speaker 2>from sex by about ninety nine percent. That's a huge drop.

0:15:25.080 --> 0:15:28.760
<v Speaker 1>Prep works by setting up fortified walls around the cell

0:15:29.080 --> 0:15:32.760
<v Speaker 1>that HIV is trying to infect, so those spike proteins

0:15:32.880 --> 0:15:35.800
<v Speaker 1>can't bind and infect and as a result of that,

0:15:35.920 --> 0:15:37.960
<v Speaker 1>they can't replicate inside the whole cell.

0:15:38.520 --> 0:15:41.560
<v Speaker 4>It's great because if people take it every day, then

0:15:41.600 --> 0:15:44.760
<v Speaker 4>it reduces their exposure to infection. However, they have to

0:15:44.800 --> 0:15:47.600
<v Speaker 4>take it every day, simply stated. You can think about

0:15:47.600 --> 0:15:50.400
<v Speaker 4>it like something such as birth control. Birth control, like

0:15:50.400 --> 0:15:52.320
<v Speaker 4>if you're taking a pill, it's usually like ninety to

0:15:52.400 --> 0:15:54.840
<v Speaker 4>ninety seven percent effective if you take it according to

0:15:54.920 --> 0:15:57.320
<v Speaker 4>the instructions. The instructions say that you have to take

0:15:57.360 --> 0:16:00.080
<v Speaker 4>the pill at the exact same time every day in

0:16:00.160 --> 0:16:02.360
<v Speaker 4>order for it to reach the efficacy For the people

0:16:02.400 --> 0:16:05.200
<v Speaker 4>that use this type of contraceptive, how many times have

0:16:05.240 --> 0:16:08.000
<v Speaker 4>you not taken it at two two pm every day?

0:16:08.040 --> 0:16:09.240
<v Speaker 3>How many times have you missed a day?

0:16:09.240 --> 0:16:11.320
<v Speaker 4>If you think about vitamins, do you take your vitamins

0:16:11.320 --> 0:16:12.200
<v Speaker 4>every day regularly?

0:16:12.240 --> 0:16:13.800
<v Speaker 3>Do you go to the gym every day regularly?

0:16:13.840 --> 0:16:16.680
<v Speaker 4>All of these behavioral things that we know will positively

0:16:16.680 --> 0:16:19.800
<v Speaker 4>impact our health and our longevity, our quality of life.

0:16:19.880 --> 0:16:21.000
<v Speaker 2>Remember T T shoes?

0:16:24.360 --> 0:16:26.720
<v Speaker 1>Yeah, if you didn't hear the shoe story, go back

0:16:26.720 --> 0:16:28.960
<v Speaker 1>and listen to the lab right before this one.

0:16:28.880 --> 0:16:39.800
<v Speaker 2>Where we talk about, you know, forgetfulness consistency. Taking a

0:16:39.800 --> 0:16:41.440
<v Speaker 2>pill every day for the rest of your life can

0:16:41.480 --> 0:16:43.440
<v Speaker 2>be costly, Like a lot of people might not have

0:16:43.480 --> 0:16:46.680
<v Speaker 2>access to the resources or insurance that allows them to

0:16:46.680 --> 0:16:48.080
<v Speaker 2>get that medication consistently.

0:16:48.360 --> 0:16:50.680
<v Speaker 4>So we need a vaccine because a vaccine will go

0:16:50.680 --> 0:16:53.880
<v Speaker 4>into healthy individuals before they have any potential for exposure

0:16:54.040 --> 0:16:56.280
<v Speaker 4>and prevent them from being infected. You take the full

0:16:56.320 --> 0:16:59.200
<v Speaker 4>regiment of the vaccine, then you're prevented from ever getting

0:16:59.280 --> 0:17:02.080
<v Speaker 4>the virus. And so even if there's a few instances

0:17:02.080 --> 0:17:04.760
<v Speaker 4>of breakthrough, majority of the population will be protected so

0:17:04.760 --> 0:17:07.200
<v Speaker 4>they will never have to do that everyday treatment or

0:17:07.240 --> 0:17:09.919
<v Speaker 4>every day preventative pill. I'm really interested in where we

0:17:09.960 --> 0:17:12.800
<v Speaker 4>are now, as we learn with COVID, getting a vaccine

0:17:12.800 --> 0:17:15.399
<v Speaker 4>approved and on the market can be a very involved,

0:17:15.560 --> 0:17:17.840
<v Speaker 4>expensive and time consuming process.

0:17:17.960 --> 0:17:21.359
<v Speaker 1>Okay, So once a novel or new vaccine candidate is

0:17:21.400 --> 0:17:24.520
<v Speaker 1>developed in a lab, it goes through a really rigorous

0:17:24.560 --> 0:17:28.199
<v Speaker 1>evaluation process where it's tested for safety and effectiveness in

0:17:28.280 --> 0:17:31.760
<v Speaker 1>humans before it's licensed for use. And this includes several

0:17:31.760 --> 0:17:35.119
<v Speaker 1>different phases of clinical trials. You probably remember hearing about

0:17:35.119 --> 0:17:37.679
<v Speaker 1>that with the COVID vaccines too, So we wanted to

0:17:37.720 --> 0:17:40.280
<v Speaker 1>know from doctor Daniels, where are we at in terms

0:17:40.359 --> 0:17:44.560
<v Speaker 1>of progress towards an effective HIV vaccine? Are we close?

0:17:44.960 --> 0:17:47.320
<v Speaker 4>Learning from my predecessors, I'm not going to stay a timeline.

0:17:47.359 --> 0:17:49.879
<v Speaker 4>What I will say is that we are having promising

0:17:50.080 --> 0:17:52.800
<v Speaker 4>results from studies that suggest that we may be on

0:17:52.840 --> 0:17:55.080
<v Speaker 4>the right path. I'm sure it's hard to predict because

0:17:55.160 --> 0:17:58.480
<v Speaker 4>historically the HIV vaccine has been pretty elusive.

0:17:58.640 --> 0:18:01.840
<v Speaker 1>In nineteen eighty four, when HIV was first determined as

0:18:01.880 --> 0:18:04.960
<v Speaker 1>the cause of AIDS, the United States Health and Human

0:18:05.000 --> 0:18:09.119
<v Speaker 1>Services Secretary Margaret Heckler said that she believed a vaccine

0:18:09.119 --> 0:18:11.920
<v Speaker 1>for HIV would be ready for testing in two years.

0:18:12.160 --> 0:18:14.920
<v Speaker 2>There have been multiple trials in different phases through the years.

0:18:15.200 --> 0:18:18.520
<v Speaker 2>Most notably, vax Gen got FDA approval for the first

0:18:18.600 --> 0:18:22.119
<v Speaker 2>large scale Phase three clinical trial of an HIV vaccine

0:18:22.160 --> 0:18:25.480
<v Speaker 2>in nineteen ninety eight. That vaccine was called vax zero

0:18:25.560 --> 0:18:29.400
<v Speaker 2>zero four, but it ultimately failed. For a deep dive

0:18:29.440 --> 0:18:32.000
<v Speaker 2>on that, check out the June second episode of Gimletz

0:18:32.040 --> 0:18:35.159
<v Speaker 2>podcast Not Pasted It, which really breaks it down.

0:18:35.000 --> 0:18:37.080
<v Speaker 1>But there was a clinical trial in two thousand and

0:18:37.160 --> 0:18:38.480
<v Speaker 1>nine with positive results.

0:18:38.800 --> 0:18:41.840
<v Speaker 4>So today the only effective trial has been by the

0:18:42.000 --> 0:18:44.280
<v Speaker 4>r one four to fourth trial that was done in

0:18:44.359 --> 0:18:47.800
<v Speaker 4>humans and it led to about thirty percent protection.

0:18:48.160 --> 0:18:51.199
<v Speaker 1>The RV one forty four trial was a partnership between

0:18:51.320 --> 0:18:54.840
<v Speaker 1>the United States and the Royal Thai governments. From two

0:18:54.880 --> 0:18:57.520
<v Speaker 1>thousand and three to two thousand and six, over sixteen

0:18:57.600 --> 0:19:01.800
<v Speaker 1>thousand people volunteered to receive a two vaccine combination, one

0:19:01.920 --> 0:19:04.639
<v Speaker 1>prime and one boost. When the results were released in

0:19:04.640 --> 0:19:07.600
<v Speaker 1>two thousand and nine, with a thirty two percent efficacy

0:19:07.640 --> 0:19:11.280
<v Speaker 1>rate for preventing HIV, it became the only trial that

0:19:11.320 --> 0:19:14.800
<v Speaker 1>had any evidence of effectiveness and remains so to date.

0:19:15.119 --> 0:19:18.399
<v Speaker 1>You need a much higher efficacy rate to get approval.

0:19:18.680 --> 0:19:22.280
<v Speaker 1>But there were some really valuable learnings from this trial that.

0:19:22.240 --> 0:19:24.280
<v Speaker 4>Enabled us to learn a lot about what type of

0:19:24.320 --> 0:19:26.280
<v Speaker 4>responses are necessary. So that's kind of when we learned

0:19:26.280 --> 0:19:29.000
<v Speaker 4>a lot of information about the fact that neutralizing and

0:19:29.119 --> 0:19:32.199
<v Speaker 4>non neutralizing antibodies contribute to the response. And people have

0:19:32.240 --> 0:19:35.640
<v Speaker 4>followed up on the things that were learned from that

0:19:35.800 --> 0:19:38.880
<v Speaker 4>study in terms of like more recently, there are preliminary

0:19:38.880 --> 0:19:41.639
<v Speaker 4>results from a lab from scripts that show that they

0:19:41.640 --> 0:19:45.000
<v Speaker 4>were able to elicit precursor antibodies that may have that

0:19:45.160 --> 0:19:47.720
<v Speaker 4>breath and potency that we want to listit pre neutralizing

0:19:47.760 --> 0:19:50.919
<v Speaker 4>antibodies and ninety seven percent of their participants, and so

0:19:51.040 --> 0:19:53.840
<v Speaker 4>that's really promising. It's not a final result, you know,

0:19:53.840 --> 0:19:57.159
<v Speaker 4>it's not we elicited neutralizing antibodies, but something that has

0:19:57.200 --> 0:20:00.880
<v Speaker 4>the potential to become a neutralizing antibody. But if that happens,

0:20:01.080 --> 0:20:02.680
<v Speaker 4>then that would jump to the front of the line

0:20:02.680 --> 0:20:03.480
<v Speaker 4>as a candidate.

0:20:08.680 --> 0:20:12.120
<v Speaker 2>So this feels like we are trending in the right direction.

0:20:12.560 --> 0:20:15.840
<v Speaker 1>Yes, all of this information from doctor Daniels has made

0:20:15.880 --> 0:20:18.080
<v Speaker 1>me very excited about the possibilities.

0:20:18.119 --> 0:20:20.440
<v Speaker 2>But I think if we've learned anything over the past

0:20:20.440 --> 0:20:23.639
<v Speaker 2>two years, it is that we are not blank canvases

0:20:23.880 --> 0:20:27.400
<v Speaker 2>for scientific advances, and that it is going to take

0:20:27.520 --> 0:20:32.119
<v Speaker 2>a lot of understanding of social dynamics and just situating

0:20:32.200 --> 0:20:34.960
<v Speaker 2>this research in the context of what's happened before and

0:20:35.000 --> 0:20:35.959
<v Speaker 2>what's happening today.

0:20:36.200 --> 0:20:38.840
<v Speaker 1>Right. I think that is such a great point because

0:20:39.080 --> 0:20:42.480
<v Speaker 1>with all that we knew before the pandemic hit, a

0:20:42.480 --> 0:20:45.040
<v Speaker 1>lot of us thought that once the vaccine came out

0:20:45.080 --> 0:20:47.399
<v Speaker 1>that everyone would be willing to take it, and that

0:20:47.560 --> 0:20:50.160
<v Speaker 1>wasn't the case. So when I think about the HIV vaccine,

0:20:50.240 --> 0:20:54.440
<v Speaker 1>I wonder what pushback there might be from the general population.

0:20:54.920 --> 0:20:57.720
<v Speaker 2>Yes, and you know, even though it is a short history,

0:20:57.720 --> 0:21:02.080
<v Speaker 2>it is a very complex history, full of medical neglect

0:21:02.359 --> 0:21:06.320
<v Speaker 2>and mismanagement in the early stages by research institutions, and

0:21:06.359 --> 0:21:09.800
<v Speaker 2>so I think there is a lot to unpack and

0:21:09.960 --> 0:21:13.360
<v Speaker 2>even just day to day general rumors that we kind

0:21:13.359 --> 0:21:15.520
<v Speaker 2>of mentioned at the top of the episode, how will

0:21:15.680 --> 0:21:19.200
<v Speaker 2>that affect how people receive new advances as it relates

0:21:19.200 --> 0:21:27.720
<v Speaker 2>to HIV. So it's time for one thing. I want

0:21:27.720 --> 0:21:29.080
<v Speaker 2>to know what's been on your mind or what you're

0:21:29.080 --> 0:21:29.680
<v Speaker 2>loving this week.

0:21:29.720 --> 0:21:32.800
<v Speaker 1>TT For me around this time of year, I think

0:21:32.880 --> 0:21:35.080
<v Speaker 1>the fields are always the same, and so my one

0:21:35.119 --> 0:21:37.960
<v Speaker 1>thing this week is friendship. This time of year always

0:21:38.000 --> 0:21:40.399
<v Speaker 1>feels difficult for a lot of people for a lot

0:21:40.440 --> 0:21:42.560
<v Speaker 1>of different reasons. Some people are far away from the

0:21:42.560 --> 0:21:44.800
<v Speaker 1>people that they love, some people have lost people that

0:21:44.840 --> 0:21:49.200
<v Speaker 1>they love. And I think that friendship, family, family, whatever

0:21:49.359 --> 0:21:52.360
<v Speaker 1>you want to call it, your chosen family, I think

0:21:52.400 --> 0:21:55.560
<v Speaker 1>that it's always super important to tap into those networks.

0:21:55.600 --> 0:21:58.439
<v Speaker 1>And so that's what's been getting me through this week,

0:21:58.640 --> 0:22:01.240
<v Speaker 1>is my friends and my family. So that's my one thing.

0:22:01.440 --> 0:22:03.040
<v Speaker 1>I love it. What's your one thing? Ze?

0:22:03.400 --> 0:22:06.160
<v Speaker 2>My one thing this week is kind of along those

0:22:06.160 --> 0:22:08.359
<v Speaker 2>same lines. I've been doing a lot of reflection and

0:22:08.400 --> 0:22:12.560
<v Speaker 2>having all the feels, and I've been using these prompts

0:22:12.600 --> 0:22:17.440
<v Speaker 2>called moonless and l I S t s. They're on Instagram,

0:22:17.440 --> 0:22:19.040
<v Speaker 2>but you can also find them I think at moonliss

0:22:19.080 --> 0:22:21.840
<v Speaker 2>dot com, and they're just open ended prompts to help

0:22:21.880 --> 0:22:25.080
<v Speaker 2>you think and reflect on how you're feeling. I think

0:22:25.119 --> 0:22:27.719
<v Speaker 2>I talked about the day one journaling app before, but

0:22:27.760 --> 0:22:29.800
<v Speaker 2>it's just something to help you kind of start to

0:22:29.840 --> 0:22:32.560
<v Speaker 2>think about what's going on, what you care about, how

0:22:32.600 --> 0:22:34.600
<v Speaker 2>you're orienting in the world day to day.

0:22:34.840 --> 0:22:38.280
<v Speaker 1>That sounds really cool, So moon lists dot com. I'm

0:22:38.320 --> 0:22:40.359
<v Speaker 1>putting it into my search engine right now.

0:22:48.840 --> 0:22:50.080
<v Speaker 2>That's it for Lab forty two.

0:22:50.359 --> 0:22:51.080
<v Speaker 3>What did you think?

0:22:51.359 --> 0:22:53.760
<v Speaker 2>Call us at two zero two five six seven seven

0:22:53.920 --> 0:22:55.280
<v Speaker 2>zero two eight and let us know.

0:22:55.560 --> 0:22:57.880
<v Speaker 1>We'd also love to hear from you for an upcoming

0:22:57.920 --> 0:23:00.440
<v Speaker 1>series we're working on for the New year. We want

0:23:00.440 --> 0:23:03.280
<v Speaker 1>to know about your New Year's resolutions for twenty twenty two.

0:23:03.480 --> 0:23:05.240
<v Speaker 1>Are you making a list or did you skip the

0:23:05.240 --> 0:23:08.560
<v Speaker 1>resolutions altogether? What are you focusing on. We want to

0:23:08.600 --> 0:23:11.360
<v Speaker 1>hear from you. Call us at two zero two five

0:23:11.440 --> 0:23:14.760
<v Speaker 1>six seven seven zero two eight and leave a message.

0:23:14.400 --> 0:23:16.439
<v Speaker 2>And don't forget. There's so much more for you to

0:23:16.480 --> 0:23:19.200
<v Speaker 2>dig into on our website. There'll be a cheat sheet

0:23:19.240 --> 0:23:22.400
<v Speaker 2>for today's lab, additional links and resources in this show notes,

0:23:22.600 --> 0:23:24.960
<v Speaker 2>Plus you can sign up for our newsletter check it

0:23:25.000 --> 0:23:27.680
<v Speaker 2>out at Dope Labs podcast dot com.

0:23:27.720 --> 0:23:31.320
<v Speaker 1>Special thanks to today's guest expert, doctor Christine Daniels.

0:23:31.440 --> 0:23:35.480
<v Speaker 2>You can find her on Twitter and Instagram at nah

0:23:35.720 --> 0:23:37.280
<v Speaker 2>Underscore m I n O.

0:23:37.560 --> 0:23:40.040
<v Speaker 1>And you can find us on Twitter and Instagram at

0:23:40.119 --> 0:23:41.200
<v Speaker 1>Dope Labs Podcast.

0:23:41.520 --> 0:23:45.120
<v Speaker 2>TT's on Twitter at dr Underscore t SHO.

0:23:45.040 --> 0:23:48.800
<v Speaker 1>And you can find Zakia at z said So. Dope

0:23:48.880 --> 0:23:52.359
<v Speaker 1>Labs is a Spotify original production from Mega Own Media Group.

0:23:52.520 --> 0:23:55.720
<v Speaker 2>Our producers are Jenny Rattleitmast and Lydia Smith of Wave

0:23:55.800 --> 0:23:56.719
<v Speaker 2>Runner Studios.

0:23:56.920 --> 0:24:01.359
<v Speaker 1>Editing in sound design by Rob Smerciak, mix by Hannes Brown.

0:24:01.640 --> 0:24:05.520
<v Speaker 1>Original music composed and produced by Taka Yasuzawa and Alex

0:24:05.600 --> 0:24:06.960
<v Speaker 1>Sugier from Spotify.

0:24:07.040 --> 0:24:10.239
<v Speaker 2>Our executive producer is Gina Delvack, and creative producers are

0:24:10.280 --> 0:24:13.040
<v Speaker 2>Baron Farmer and Candace Manriquez Wrinn.

0:24:12.960 --> 0:24:17.439
<v Speaker 1>Special thanks to Shirley ramos yasmin of Fifi, camu Elolia,

0:24:17.880 --> 0:24:21.600
<v Speaker 1>Till krat Key, and Brian Marquis. Executive producers from Mega

0:24:21.600 --> 0:24:24.080
<v Speaker 1>Oh Media Group are US T T Show, Dia and

0:24:24.160 --> 0:24:40.240
<v Speaker 1>Zakiah Wattley. That's great.

0:24:40.520 --> 0:24:42.040
<v Speaker 2>One take Jake this time